Spasticity is involuntary overactivity of muscles that occurs following upper motor neuron damage to the brain or spinal cord. Upper limb spasticity is common after stroke and can cause deformity, ...

LONDON — Arbaclofen extended-release tablets (Biogen) can decrease spasticity related to multiple sclerosis (MS), with a better safety profile than the commonly used spasticity-fighting drug baclofen, ...

Arbaclofen extended-release (ER) reduced spasticity in patients with multiple sclerosis and was found to be safe and well-tolerated, according to 2 new abstracts presented at the 33rd Annual Meeting ...

Investigators sought to determine the safety and efficacy of twice-daily dosing of arbaclofen ER in patients with spasticity due to multiple sclerosis. SEATTLE – Twice-daily arbaclofen ...

Spasticity is a clinical sign characterized by muscle over-activity and high tone spasms that is associated with several distinct neurological diseases. Timely diagnosis and management are essential ...

Researchers have developed a sensor-filled glove that doctors could wear to accurately measure muscle stiffness, known as spasticity, in patients suffering from stroke, cerebral palsy, multiple ...

Spasticity is a condition involving an involuntary increase in muscle tone that leads to resistance against normal movements of the body and may cause pain in some individuals. This condition is ...

Almirall S.A. (ALM) today announces that results of the MObility ImproVEments with Spasticity in Multiple Sclerosis (MOVE) 2 observational study performed in Germany, with 300 patients, showed that ...